Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents

Throughout the last decades, newly developed chemotherapeutic agents and immunotherapies that target signaling pathways have provided patients with better prognoses, improved their quality of life and increased survival rates, thus converting cancer to a stable chronic disease. However, non-anthracy...

Full description

Bibliographic Details
Main Authors: Alexandros Briasoulis, Angeliki Chasouraki, Alexandros Sianis, Nikolaos Panagiotou, Christos Kourek, Argyrios Ntalianis, Ioannis Paraskevaidis
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
cardiotoxicity
cardiac dysfunction
non-anthracycline agents
chemotherapy
immunotherapy
cardioprotection
Online Access:https://www.mdpi.com/2308-3425/9/3/66

Internet

https://www.mdpi.com/2308-3425/9/3/66

Similar Items